Table 4 Details of PEP patients
| No | Gendera | Age | Indication | Cannulation methods | Pancreatic cannulation | Biliary access | EPBD | Prophylaxis | Severity of PEP |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 50- 59 | CBD stone | NKF | 0 | Yes | Y | none | Mild |
| 2 | 2 | 60- 69 | Pancreatic cancer | NKF | 0 | Yes | Y | none | Mild |
| 3 | 2 | 80- 89 | Pancreas head tumor | NKF | 0 | Yes | N | none | Mild |
| 4 | 1 | 60- 69 | CBD stone | TPS | 4 | Yes | Y | NSAID + gabexate | Mild |
| 5 | 2 | 60- 69 | Cholangiocarcinoma | TPS | 12 | No | N | none | Mild |
| 6 | 2 | 30- 39 | CBD stone | TPS | 5 | Yes | N | NSAID + gabexate | Mild |
| 7 | 1 | 40- 49 | Pancreatic cancer | TPS | 12 | No | N | P stent + NSAID + gabexate | Mild |
| 8 | 1 | 60- 69 | CBD stone | TPS | No | Yes | Y | NSAID + gabexate | Mild |